Uros Mazic
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Uros Mazic has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Alenka Šmid
Faculty of pharmacy, University of Ljubljana, Aškerčeva cesta 7, 1000 Ljubljana, the Republic of Slovenia
1 shared publication - Berta Jereb
Institute of Oncology, Zaloška 2, Ljubljana, Slovenia
1 shared publication - Borut Gersak
Faculty of Medicine, University of Ljubljana, 1000 Ljubljana, Slovenia
1 shared publication - Ciril Krzisnik
University Children's Hospital Ljubljana, Vrazov trg 1, Ljubljana, Slovenia
1 shared publication - Damjan Demsar
Institut "Jožef Stefan", Jamova cesta 39, 1000 Ljubljana, Slovenia
1 shared publication - Irena Mlinarič-Raščan
Faculty of Pharmacy, University of Ljubljana, Ljubljana, Slovenia
1 shared publication
Latest Publications
- Open Access
- 24 May 2022
- Published by MDPI AG in Journal of Cardiovascular Development and Disease
- Vol. 9 (6) , 166
A Common Polymorphism in the MTHFD1 Gene Is a Modulator of Risk of Congenital Heart Disease
Several environmental and genetic factors may influence the risk of congenital heart defects (CHDs), which can have a substantial impact on pediatric morbidity and mortality. We investigated the association of polymorphisms in the genes of the folate and methionine pathways with CHDs using different strategies: a case–control, mother–child pair design, and a family-based association study. The polymorphism rs2236225 in the MTHFD1 was confirmed as an important modulator of CHD risk in both, whereas polymorphisms in MTRR, FPGS, and SLC19A1 were identified as risk factors in only one of the models. A strong synergistic effect on the development of CHDs was detected for MTHFD1 polymorphism and a lack of maternal folate supplementation during early pregnancy. A common polymorphism in the MTHFD1 is a genetic risk factor for the development of CHD, especially in the absence of folate supplementation in early pregnancy.
- 24 May 2022
- Published by MDPI AG in Journal of Cardiovascular Development and Disease
- Vol. 9 (6) , 166
Open AccessA Common Polymorphism in the MTHFD1 Gene Is a Modulator of Risk of Congenital Heart Disease
Several environmental and genetic factors may influence the risk of congenital heart defects (CHDs), which can have a substantial impact on pediatric morbidity and mortality. We investigated the association of polymorphisms in the genes of the folate and methionine pathways with CHDs using different strategies: a case–control, mother–child pair design, and a family-based association study. The polymorphism rs2236225 in the MTHFD1 was confirmed as an important modulator of CHD risk in both, whereas polymorphisms in MTRR, FPGS, and SLC19A1 were identified as risk factors in only one of the models. A strong synergistic effect on the development of CHDs was detected for MTHFD1 polymorphism and a lack of maternal folate supplementation during early pregnancy. A common polymorphism in the MTHFD1 is a genetic risk factor for the development of CHD, especially in the absence of folate supplementation in early pregnancy.
- Open Access
- 20 May 2008
- Published by Springer Nature in BMC Cancer
- Vol. 8 (1) , 141
Cardiac damage after treatment of childhood cancer: A long-term follow-up
With improved childhood cancer cure rate, long term sequelae are becoming an important factor of quality of life. Signs of cardiovascular disease are frequently found in long term survivors of cancer. Cardiac damage may be related to irradiation and chemotherapy.
- 20 May 2008
- Published by Springer Nature in BMC Cancer
- Vol. 8 (1) , 141
Open AccessCardiac damage after treatment of childhood cancer: A long-term follow-up
With improved childhood cancer cure rate, long term sequelae are becoming an important factor of quality of life. Signs of cardiovascular disease are frequently found in long term survivors of cancer. Cardiac damage may be related to irradiation and chemotherapy.
- 1 September 2001
- Published by Elsevier in American Heart Journal
- Vol. 142 (3) , 482-488
The role of transesophageal echocardiography in transcatheter closure of secundum atrial septal defects by the Amplatzer septal occluder
- 1 September 2001
- Published by Elsevier in American Heart Journal
- Vol. 142 (3) , 482-488
The role of transesophageal echocardiography in transcatheter closure of secundum atrial septal defects by the Amplatzer septal occluder